Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Rociletinib |
| Trade Name | |
| Synonyms | CO1686|AVL-301|CNX-419|CS-1631|CO-1686 |
| Drug Descriptions |
Rociletinib (CO-1686) is a third-generation EGFR TKI inhibitor and inhibits mutant forms of EGFR including T790M (PMID: 24410791, PMID: 32528828). |
| DrugClasses | EGFR Inhibitor 3rd gen 28 |
| CAS Registry Number | 1374640-70-6 |
| NCIT ID | C99905 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Afatinib + Rociletinib | Afatinib Rociletinib | 0 | 0 |
| Atezolizumab + Rociletinib | Atezolizumab Rociletinib | 0 | 1 |
| Bosutinib + Rociletinib | Bosutinib Rociletinib | 0 | 0 |
| Cetuximab + Rociletinib | Cetuximab Rociletinib | 0 | 0 |
| Crizotinib + Rociletinib | Crizotinib Rociletinib | 0 | 0 |
| Dasatinib + Rociletinib | Dasatinib Rociletinib | 0 | 0 |
| Rociletinib | Rociletinib | 0 | 7 |